The University of Chicago Header Logo

Connection

David Rubin to Tacrolimus

Back to Details
This is a "connection" page, showing publications David Rubin has written about Tacrolimus.
David Rubin
Connection Strength
0.127
Tacrolimus
  1. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.